AUM $9.7MER 0.68%NAV $19.34Holdings 57Inception Jun 2020
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
1.2KDividend Yield
0.46%Expense Ratio
0.68%AUM
$9.7MShares Outstanding
500.4KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 99.30% |
| Cash & Others | 0.35% |
| Financial Services | 0.35% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 81.91% |
| Germany | 6.93% |
| United Kingdom | 5.39% |
| China | 3.60% |
| France | 0.92% |
| Japan | 0.89% |
| Other | 0.35% |
Fund Information
- Issuer
- Amplify
- Category
- Healthcare
- Types
- Healthcare
- Inception Date
- Jun 18, 2020
- Description
- The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
Similar ETFs
The ETFMG Treatments, Testing and Advancements ETF (GERM) is an exchange-traded fund issued by Amplify that launched on Jun 18, 2020. It currently manages $9.7M in assets under management. The fund charges an expense ratio of 0.68%. The fund holds 57 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 54.6% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | ALNY | Alnylam Pharmaceuticals Inc | 11.39% | 3,957 | $1.1M |
| 2 | LH | Labcorp Holdings Inc | 7.20% | 2,978 | $674K |
| 3 | DGX | Quest Diagnostics Inc | 6.61% | 4,142 | $618K |
| 4 | BNTX | BioNTech SE | 5.01% | 5,803 | $469K |
| 5 | BIO | Bio-Rad Laboratories Inc | 4.74% | 1,363 | $443K |
| 6 | PCVX | Vaxcyte Inc | 4.52% | 5,432 | $423K |
| 7 | QDEL | QuidelOrtho Corp | 4.11% | 9,250 | $385K |
| 8 | BCRX | BioCryst Pharmaceuticals Inc | 3.70% | 45,426 | $347K |
| 9 | IMCR | Immunocore Holdings PLC | 3.67% | 9,226 | $343K |
| 10 | ZLAB | Zai Lab Ltd | 3.60% | 20,729 | $337K |
| 11 | MRNA | Moderna Inc | 3.46% | 3,819 | $324K |
| 12 | DVAX | Dynavax Technologies Corp | 3.42% | 28,811 | $320K |
| 13 | IBRX | ImmunityBio Inc | 3.14% | 64,671 | $294K |
| 14 | VIR | Vir Biotechnology Inc | 2.79% | 29,948 | $261K |
| 15 | NVAX | Novavax Inc | 2.50% | 20,141 | $234K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | — | |
| 1W | — | |
| 1M | — | |
| 3M | — | |
| 6M | — | |
| YTD | — | |
| 1Y | — | |
| 3Y | -8.94% | |
| 5Y | -49.62% |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
$19.16
52-Week Low
—
Current Yield
0.46%
Annual Dividend
$0.2360
Frequency
4x/year
Last Ex-Date
Jun 27, 2024
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Jun 27, 2024 | $0.0880 | Jun 28, 2024 |
| Mar 26, 2024 | $0.0558 | Mar 28, 2024 |
| Dec 27, 2023 | $0.0522 | Dec 29, 2023 |
| Sep 20, 2023 | $0.0400 | Sep 22, 2023 |
| Jun 21, 2023 | $0.0600 | Jun 23, 2023 |
| Mar 22, 2023 | $0.0900 | Mar 24, 2023 |
| Dec 28, 2022 | $0.0286 | Dec 30, 2022 |
| Sep 21, 2022 | $0.0600 | Sep 23, 2022 |
| Jun 22, 2022 | $0.0500 | Jun 24, 2022 |
| Dec 28, 2021 | $0.0010 | Dec 30, 2021 |
| Sep 21, 2021 | $0.0400 | Sep 23, 2021 |
| Jun 22, 2021 | $0.0600 | Jun 24, 2021 |
| Dec 14, 2020 | $0.2850 | Dec 16, 2020 |
Dividend Payments Over Time
Category Comparison
| Metric | GERM | Healthcare(212 ETFs) | Healthcare(24 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.68% | 0.61% | 0.48% |
| AUM | $9.7M | $1.20B | $625.2M |
| Dividend Yield | 0.46% | 3.25% | 1.61% |
| Avg Volume | 1.2K | 339.2K | 80.5K |
| Holdings | 57 | 181 | 137 |
| Performance | |||
| 1-Month Return | — | +7.61% | +4.87% |
| 6-Month Return | — | +4.67% | +2.58% |
| YTD Return | — | +1.95% | -1.12% |
| 1-Year Return | — | +27.17% | +19.43% |
Compare with Another ETF
Search for an ETF to compare with GERM:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.